Isoray To Announce First Quarter Fiscal 2023 Financial Results on November 10, 2022
Isoray, Inc. (NYSE AMERICAN: ISR) announces a conference call on November 10, 2022, at 4:30 p.m. ET to discuss its first quarter fiscal 2023 financial results, which ended on September 30, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Isoray, Inc. (NYSE AMERICAN: ISR) announces a conference call on November 10, 2022, at 4:30 p.m. ET to discuss its first quarter fiscal 2023 financial results, which ended on September 30, 2022. A press release detailing these results will be issued after the U.S. markets close on the same day. Interested parties can listen by calling (877) 545-0320, with an international line available at (973) 528-0002. The call will also be webcast, available for later viewing until February 10, 2023.
Details
News Market Reaction – ISR
The recorded move for ISR in the trading session of this news was -4.97%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Call is Thursday, November 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, Wash., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that it will host a conference call to discuss its financial results for the first quarter fiscal 2023 ended September 30, 2022 on Thursday, November 10, 2022, at 4:30 p.m. Eastern Time. The Company will issue a press release announcing its financial results for the first quarter fiscal year 2023 after the close of the U.S. stock markets on November 10, 2022.
To listen to the conference call, please dial (877) 545-0320. For callers outside the U.S., please dial (973) 528-0002.
The conference call will be simultaneously webcast and can be accessed at https://www.webcaster4.com/Webcast/Page/2199/46923. The webcast will be available until February 10, 2023 following the conference call.
About Isoray
Isoray, Inc. is a medical technology company pioneering advanced treatment applications and devices to deliver targeted internal radiation treatments for cancers throughout the body. Isoray, Inc., through its subsidiary, Isoray Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and Twitter.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.